Navigation Links
One Man's 'Fortified' Bread is Another's Poison

One of Australia's biggest bread companies is not happy with the proposal to fortify all available brands of bread with folic acid. They are petitioning the state and federal// governments to veto this proposal.

The objective of such a proposal is to enhance the foliate levels in women of child-bearing age. The folic acid fortification will help offset birth defects, such as spina bifida.

If you ask Ian Greenshields from Goodman Fielder about what he thinks of the proposal, he says it is akin to stuffing foliate enriched bread down people's throat , whether they like it or not. The choice should rest with the consumers, he affirms.

'You're going to be dosing 26 million people to try and prevent about 30 birth defects per year. So it doesn't seem to make a lot of sense, particularly when there's a lot that's unknown about the long-term effects of folic acid.' He said.

Today, the subject is being debated by the powers that be at Brisbane. /B
'"/>




Page: 1

Related medicine news :

1. Dog (Mans best friend) Genome Sequenced
2. Mans Transition from Foragers to Agriculturalist Led to Increase in Birth Rates
3. Mans Memory Awakens After Twenty Years
4. Doctors Remove Four-cm Long Pin from Mans Lungs
5. NZ To Opt For Folate Fortification Of Bread
6. Opposition to Compulsory Fortification of Bread with Folic Acid
7. Bread enriched with lupin may help stave off calories
8. Folic Acid Supplementation in Bread: Boon to Neonates and Curse to Pensioners
9. Gluten Free Bread: Boon for Celiac Disease
10. Too Much of Salt in Bread..
11. Poisonous Parkinsons molecule discovered
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: One Man Fortified Bread Another Poison

(Date:12/6/2009)... Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today ... 2b 003-A1 study, known as the 003 trial, ... relapsed and refractory multiple myeloma patients. These data ... at the 51st annual meeting of the American ... in this trial is complete (n=269), and full ...
(Date:12/6/2009)... Sickle cell disease, a condition characterized ... one of the most common genetic blood disorders ... more than 70,000 Americans.(1) Research presented today at ... of Hematology highlights intriguing studies on the acute ... with this blood disorder, evaluations of both new ...
(Date:12/6/2009)... Blood clotting, or coagulation, is an important process ... is injured. Sometimes, however, clots form on the ... do not dissolve naturally, a potentially life-threatening situation ... Annual Meeting of the American Society of Hematology ... aspirin and heparin with the hope of preventing ...
(Date:12/6/2009)... 2009 A new study provides welcome news for ... thromboembolism (VTE). , The condition is estimated to ... occurs when an abnormal clot forms in a vein ... swelling. In some cases, the clot may detach from ... to the lungs, causing a potentially fatal condition known ...
(Date:12/6/2009)... Disorders information and Treatment site www.sleeping-with-a-sleeping-disorder.com ... with herbal or natural sleep aids from around ... for a good cause. The submissions will be ... Aids ,Encyclopedia, by YOU, to be sold from ... will donate 100% of the proceeds ,from sales ...
Breaking Medicine News(10 mins):Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 2Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 3Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 4Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 5Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 2Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 3Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 4Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 5Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 6Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 7Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 8Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 9Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 2Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 3Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 4Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 5Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 6Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 7Health News:New drug shows promise for those with clotting disorders: McMaster researcher 2Health News:Donate a Herbal Natural Sleep Aid to the Internet's First "Natural Sleep Aids E-book" Written by People Just Like You 2
... simple in their diet can help avert the 'cancer timebomb' facing ... ,Dr Greg Martin said that the UK is facing a 'cancer ... added that people must start eating right and exercising, as few ... of the hormone oestrogen, which can be carcinogenic. , ...
... warned against the bird flu situation in Bangladesh and ... strategy to control the deadly H5N1 strain, the FAO said. ... reported in Bangladesh, some 157,000 chickens have been culled and ... out of 64 districts since the first outbreak, announced in ...
... to data available, in 2002 almost 65,000 Americans died ... infection is the seventh leading cause of death in the ... to help ward off viral diseases, but a new report ... likelihood of catching pneumonia, at least among well-nourished women. ...
... The quote there is nothing as lovely as the feet of ... There is finally, good news from the University of Chicago Comer ... side effects of the smallpox vaccine, and unfortunately, on a toddler, ... seven weeks in the hospital and nearly died from a viral ...
... can slow their progression to dementia by having up to ... suggested . ,The study published in the May ... American Academy of Neurology. ,Mild cognitive impairment is ... used to categorize people with mild memory or cognitive problems ...
... of concentrated radio waves appears to be a safe and ... esophagus that can be a precursor of cancer . ... Barrett's esophagus, a condition associated with the continued reflux of ... lining over time. While this condition is relatively common, a ...
Other Medicine News:Health News:Simple Lifestyle Diet Changes can Diffuse 'Cancer Timebomb' 2Health News:Bird Flu: Bangladesh Situation Serious, Indian on High Alert 2Health News:Vitamins may Not Ward Off Pneumonia 2Health News:Toddler Infected With Rare Side Effect Of Smallpox Vaccination Recovering 2Health News:Toddler Infected With Rare Side Effect Of Smallpox Vaccination Recovering 3Health News:A Drink a Day may Delay Dementia Progression 2Health News:New Approach to Treating Precancerous Esophagus Condition 2Health News:New Approach to Treating Precancerous Esophagus Condition 3
(Date:12/6/2009)... RNL Bio Co., Ltd, ( www.rnl.co.kr ) a ... therapeutics announced today that a 46-year-old female, Kang ... stem cell treatment. Park was suffering from MS ... central nervous system (brain and spinal cord). ... the nerves of the central nervous system degenerate. ...
(Date:12/4/2009)... 4 A new, $2.8 million, four-year federal grant ... of Medicine and their collaborators at Wake Forest University ... blood degrades over time and how to address the ... been associated with increased risk for cardiovascular events and ...
(Date:12/4/2009)... simple, inexpensive computer tool that measures volume changes in ... up by a CT scanner can rule out non-cancerous ... diagnose true cancers with fewer, less expensive and less ... new diagnostic guidelines are described in a paper published ...
Breaking Medicine Technology:Multiple Sclerosis Patient Finds Hope Through Stem Cell Treatment 2NHLBI Grant Awarded to Wake Forest, Pitt to Improve Banked Blood 2NHLBI Grant Awarded to Wake Forest, Pitt to Improve Banked Blood 3European Lung Cancer Screening Trial Demonstrates New Inexpensive Strategy for Improving Accuracy of Diagnosis 2Ganeden Biotech Liquid Health Labs Unveil New Drink Technology 12471 1Ganeden Biotech Liquid Health Labs Unveil New Drink Technology 12471 2Ganeden Biotech Liquid Health Labs Unveil New Drink Technology 12471 3Fora Care Inc to Launch Cost Effective Solution for Diabetes Care at ADA 69th Scientific Sessions 47911 1Fora Care Inc to Launch Cost Effective Solution for Diabetes Care at ADA 69th Scientific Sessions 47911 2Cantel Medical Reports a 109 25 Increase in Net Income EPS of 240 25 vs 240 12 for Quarter Ended April 30 2009 47909 1Cantel Medical Reports a 109 25 Increase in Net Income EPS of 240 25 vs 240 12 for Quarter Ended April 30 2009 47909 2Cantel Medical Reports a 109 25 Increase in Net Income EPS of 240 25 vs 240 12 for Quarter Ended April 30 2009 47909 3Cantel Medical Reports a 109 25 Increase in Net Income EPS of 240 25 vs 240 12 for Quarter Ended April 30 2009 47909 4Cantel Medical Reports a 109 25 Increase in Net Income EPS of 240 25 vs 240 12 for Quarter Ended April 30 2009 47909 5Cantel Medical Reports a 109 25 Increase in Net Income EPS of 240 25 vs 240 12 for Quarter Ended April 30 2009 47909 6Cantel Medical Reports a 109 25 Increase in Net Income EPS of 240 25 vs 240 12 for Quarter Ended April 30 2009 47909 7
... Miami Breast Cancer Conference, study demonstrates BSGI is ... both patient and ... recent study performed by,Dr. Margaret Bertrand, Director of Breast Imaging ... significant value of,Breast-Specific Gamma Imaging (BSGI) as an adjunctive procedure ...
... of the Phase 1 Program for R4996/MEM 63908 -, ... MEMY ), a biopharmaceutical company focused,on the discovery ... a broad range of central nervous system (CNS) conditions,today ... year ended,December 31, 2007., "We have made significant ...
Other Medicine Technology:Bertrand Study Finds Significant Value in Breast-Specific Gamma Imaging (BSGI) as an Adjunctive Procedure in Breast Diagnostics 2Bertrand Study Finds Significant Value in Breast-Specific Gamma Imaging (BSGI) as an Adjunctive Procedure in Breast Diagnostics 3Memory Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Financial Results 2Memory Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Financial Results 3Memory Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Financial Results 4Memory Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Financial Results 5Memory Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Financial Results 6Memory Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Financial Results 7Memory Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Financial Results 8Memory Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Financial Results 9
The MPF cup is specifically designed to achieve high primary stability, a critical factor for long term success....
... The integration of Trabecular Metal ... implant design results in a fusion ... only meets surgeon demands for initial ... a wide variety of shell and ...
The Trilogy system builds on the success of the Harris/Galante Porous and HGP II cups by combining proven features with new technology designed to inhibit the formation and migration of polyethylene ...
For primary and revision cases...
Medicine Products: